Yoav Avidor is Vice President of R&D, Product Development, Regulatory Affairs and Innovation at Adama, a provider of solutions to farmers with $5.0 billion in sales.
Yoav is responsible for Adama's product pipeline which is based on chemical and formulation R&D, biologicals, field trials, registration and innovation.
Prior to joining Adama in 2013 Yoav was CEO of Cheetah Medical, a medical device company (acquired by Baxter since then).
Prior to that Yoav was global marketing director at Johnson & Johnson where he led bariatric marketing (weight loss surgical solutions).
Yoav trained as a physician and holds an MD from Tel Aviv university and MBA from Kellogg in Chicago.